References
Cohen MA, Huband MD, Mailloux GB, Yoder SL, Roland GE, et al. In-vitro antibacterial activities of PD 131628, anew 1,8 naphthyridine antiinfective agent. Antimicrobial Agents and Chemotherapy 35: 141–146, 1991
Fuchs PC, Barry AL, Phaller MA, Allen SD, Gerlach EH. Multicenter evaluation of the in-vitro activities of three new quinolones, sparfloxacin, CI-960 and PD131628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 35: 664–766, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Callanan, J.J., Roditi, D.O.J. & Forder, A.A. Comparative In Vitro Antibacterial Activity of PD 131628, the Active Metabolite of CI-990. Drugs 45 (Suppl 3), 192–193 (1993). https://doi.org/10.2165/00003495-199300453-00047
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199300453-00047